Sanofi (SAN.PA)

Exchange: Euronext Paris
Currency: EUR

Price: 88.44 (Close)



52 Week range 200d Moving Avg. Beta
71.74 – 95.06 85.20 0.46
Dividend Dividend Yield Ex-Dividend date
3.07 3.38% 2019-05-09
P/E Ratio Latest EPS DGR 3 years
39.39 2.25 2.06%
Very low Volatility
Dividend Growth


Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia; and Cablivi to treat acquired thrombotic thrombocytopenic purpura. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, for hematologic malignancies; and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. Sanofi has an alliance with Verily Life Sciences LLC; and agreement with Happify Health. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.


Sector: Industry:
Healthcare Drug Manufacturers – Major

Environment, Social and Governance (ESG) Ratings

Total ESG Score

32 – 48 percentile


7 – 7 percentile


20 – 7 percentile


17 – 7 percentile

Controversy level


Sanofi (SAN.PA) Valuation

Sanofi current dividend yield of 3.38% is -10% below its 5-year average. The 5-year average dividend yield is 3.77% (see red-line in chart). This indicates the stock looks overvalued today.

Sanofi (SAN.PA) Performance

The chart below displays the total price return(%) of Sanofi for different periods:


Sanofi (SAN.PA) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Sanofi for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
3.38 3.07 136.44% 24 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 2.06%
5 Year Growth Rate (CAGR) 1.81%
10 Year Growth Rate (CAGR) 3.88%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2019 3.070 1.3%
2018 3.030 2.4%
2017 2.960 1.0%
2016 2.930 2.8%
2015 2.850 1.8%
2014 2.800 1.1%
2013 2.770 4.5%
2012 2.650 6.0%
2011 2.500 4.2%
2010 2.400 9.1%
2009 2.200 6.3%
2008 2.070 18.3%
2007 1.750 -4.4%
2006 1.830 23.6%
2005 1.480 45.1%

Sanofi (SAN.PA) Dividend Payment History